Gabapentin for the Treatment of Neuroleptic-Induced Tremor

Stopped early · Phase 3

Conditions studied: Neuroleptic-Induced Tremor

In brief

We will attempt to establish whether gabapentin as compared with placebo will reduce the severity of tremors caused by the use of antipsychotic medications. Baseline severity of tremor will be measured using both clinical ratings and ratings obtained with an instrument designed to measure tremor, giving more objective evidence of tremor frequency and severity.

Key facts

Study ID

NCT00533455

Run by

Minneapolis Veterans Affairs Medical Center

People needed

40

Starts

2004-03-01

Expected to finish

2007-08-01

Last updated by the study team

2007-09-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Veterans 18 and older with an observable tremor judged to be caused by exposure to antipsychotics

You may not qualify if…

• Concomitant use of other anticonvulsants, L-Dopa, cocaine, amphetamines, or other tremorogenic agents excepting SSRIs, TCAs.
• Current suicidality, severe psychosis, inability to sign informed consent or to cooperate with study procedures.
• Current use of gabapentin or exposure to gabapentin in the past 2 years.
• Women who are pregnant, or not using adequate birth control.

Where it is running

• Minneapols VA Medical Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.